S. Gratsianskaya

[The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat].

T. Martynyuk, Z. Valieva, S. Gratsianskaya, 2020, Terapevticheskii arkhiv.

Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension

T. Martynyuk, O. Arkhipova, S. Gratsianskaya, 2018, Systemic Hypertension.

COMPARATIVE CLINICAL CHARACTERISTICS OF PATIENTS WITH VARIOUS FORMS OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASE, ACCORDING TO THE CLINICAL CLASSIFICATION

T. Martynyuk, S. Gratsianskaya, 2019, Eurasian heart journal.

The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.

I. Chazova, S. Nedogoda, T. Martynyuk, 2018, Terapevticheskii arkhiv.